Jeremy L. Stigall - 29 Dec 2023 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: GM, Biologics & Drug Delivery
Signature: /s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Issuer symbol: CLPT
Transactions as of: 29 Dec 2023
Net transactions value: +$2,181
Form type: 4
Filing time: 03 Jan 2024, 20:52:37 UTC
Previous filing: 07 Jul 2023
Next filing: 23 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLPT	Common Stock	Award	$2,181	+378	+0.89%	$5.77	43,024	29 Dec 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 2023 through December 31, 2023. In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first business day or last business day of the purchase period.